Study of Heart and Lung Health in Adults After COVID-19 Infection Including ICU, Non-ICU, and Non-Hospitalized Survivors and Comparison With People Without COVID-19

What this Trial Is About

Researchers are conducting a study to better understand the degree and severity of lung and heart injury caused by COVID-19, as well as the short- and long-term effects of the infection. This study focuses on patients who have recently been diagnosed with COVID-19, including those who were treated in the ICU, hospitalized, or not hospitalized. It also aims to assess mental health and quality of life after COVID-19 infection. Participants will undergo various assessments including chest imaging, MRI, echocardiograms, spirometry, and blood tests to gather information about heart and lung structure and function. Questionnaires will be used to evaluate mental health indicators such as depression and anxiety. The study includes both COVID-19 patients and a control group without a history of COVID-19. During the study, participants will be monitored for up to 12 months. Researchers will measure inflammatory markers and collect questionnaire data on breathlessness and caregiver burden. The study involves assessments of lung and heart function, mental health, and quality of life over time to provide a comprehensive understanding of COVID-19 survivorship and its impacts.

COVID-19 Survivorship Registry